Literature DB >> 60763

Evidence for a gonadotropin from nonpregnant subjects that has physical, immunological, and biological similarities to human chorionic gonadotropin.

H C Chen, G D Hodgen, S Matsuura, L J Lin, E Gross, L E Reichert, S Birken, R E Canfield, G T Ross.   

Abstract

Substances from urinary extracts of normal, nonpregnant subjects and human pituitary gonadotropin preparations were found to react similarly to human chorionic gonadotropin (hCG) in a radioimmunoassay system that is highly specific for hCG and without crossreactivity to human luteinizing hormone (hLH). The antiserum was produced in a rabbit immunized with a bovine albumin conjugate of the unique carboxyl-terminal peptide (residues 123-145) isolated from a tryptic digest of the reduced, S-carboxymethylated hCGbeta subunit. The antibody recognition site on the peptide was found to reside on the last 15 amino acid residues of the carboxyl-terminal peptide, as evidenced by the competitive binding activities against 125I-labeled hCG of a series of peptides chemically synthesized according to the carboxyl-terminal sequence of HCGbeta. In order to elucidate the nature of the crossreacting substance in urinary extracts, a human postmenopausal urinary preparation (Pergonal) and a kaolin-acetone extract of urine from a patient with Klinefelter's syndrome were subjected to gel chromatography on Sephadex G-100. The results indicate that fractions showing immunocrossreactivity with the antiserum to hCGbeta-carboxyl-terminal peptide coeluted with 125I-labeled hCG which was separated distinctly from hLH. The same fractions from this postmenopausal urinary gonadotropin preparation exhibited in vitro biological activity proportional to the immunocrossreactivity of the hCG-specific antiserum. Concentration of postmenopausal women's urine by acetone precipitation retained approximately five times more immunoreactivity per unit volume than kaolin-acetone extraction, when assayed with the antiserum to hCGbeta-carboxyl-terminal peptide.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 60763      PMCID: PMC430789          DOI: 10.1073/pnas.73.8.2885

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  The amino acid sequence of human chorionic gonadotropin. The alpha subunit and beta subunit.

Authors:  F J Morgan; S Birken; R E Canfield
Journal:  J Biol Chem       Date:  1975-07-10       Impact factor: 5.157

2.  SOLID-PHASE PEPTIDE SYNTHESIS. 3. AN IMPROVED SYNTHESIS OF BRADYKININ.

Authors:  R B MERRIFIELD
Journal:  Biochemistry       Date:  1964-09       Impact factor: 3.162

3.  Contamination of gonadotropin standards.

Authors:  A ALBERT; I DERNER
Journal:  J Clin Endocrinol Metab       Date:  1960-10       Impact factor: 5.958

4.  PURIFICATION OF GONADOTROPHIN FROM HUMAN MENOPAUSAL URINE.

Authors:  P DONINI; D PUZZUOLI; R MONTEZEMOLO
Journal:  Acta Endocrinol (Copenh)       Date:  1964-03

5.  Human urinary gonadotropin.

Authors:  A ALBERT
Journal:  Recent Prog Horm Res       Date:  1956

6.  A highly sensitive in vitro bioassay for luteinizing hormone and chorionic gonadotropin: testosterone production by dispersed Leydig cells.

Authors:  M L Dufau; C R Mendelson; K J Catt
Journal:  J Clin Endocrinol Metab       Date:  1974-09       Impact factor: 5.958

7.  The clinical application of a specific radioimmunoassay for human chorionic gondotropin in trophoblastic and nontrophoblastic tumors.

Authors:  D P Goldstein; T S Kosasa; A T Skarim
Journal:  Surg Gynecol Obstet       Date:  1974-05

8.  Absence of neutralizing effect of antisera to the unique structural region of human chorionic gonadotropin.

Authors:  J P Louvet; G T Ross; S Birken; R E Canfield
Journal:  J Clin Endocrinol Metab       Date:  1974-12       Impact factor: 5.958

9.  Presence in normal human testes of a chorionic-gonadotropin-like substance distinct from human luteinizing hormone.

Authors:  G D Braunstein; J Rasor; M E Wade
Journal:  N Engl J Med       Date:  1975-12-25       Impact factor: 91.245

10.  Human chorionic gonadotropin as a tumor marker.

Authors:  J L Vaitukaitis
Journal:  Ann Clin Lab Sci       Date:  1974 Jul-Aug       Impact factor: 1.256

View more
  16 in total

Review 1.  Endocrine paraneoplastic syndromes with special reference to the elderly.

Authors:  L Bollanti; G Riondino; F Strollo
Journal:  Endocrine       Date:  2001-03       Impact factor: 3.633

2.  Production of choriogonadotropin-like factor by a microorganism.

Authors:  T Maruo; H Cohen; S J Segal; S S Koide
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

3.  Establishment of clonal human placental cells synthesizing human choriogonadotropin.

Authors:  J Y Chou
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

Review 4.  Current trends in antifertility vaccine research.

Authors:  D C Covey; K D O'Brien; D E Moore
Journal:  West J Med       Date:  1985-02

5.  In vivo effect of human chorionic gonadotropin on the migration of inflammatory cells in intact or castrated male and female guinea-pigs. A quantitative histological study. I. Study of intact male and female guinea-pigs.

Authors:  R Senelar; J P Bureau
Journal:  Br J Exp Pathol       Date:  1979-10

6.  Efficient extraction and sensitive radioimmunoassay for hCG in human urine.

Authors:  T Shimizu; S Matsuura; M Mochizuki
Journal:  Arch Gynecol       Date:  1984

Review 7.  New discoveries on the biology and detection of human chorionic gonadotropin.

Authors:  Laurence A Cole
Journal:  Reprod Biol Endocrinol       Date:  2009-01-26       Impact factor: 5.211

8.  Metabolic and renal clearance rates of purified human chorionic gonadotropin.

Authors:  R E Wehmann; B C Nisula
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

9.  Ectopic human chorionic gonadotropin in breast carcinoma.

Authors:  A Castro; P Buschbaum; M Nadji; W Voigt; S Tabei; A Morales
Journal:  Experientia       Date:  1979-10-15

Review 10.  Human chorionic gonadotrophin and sport.

Authors:  A T Kicman; R V Brooks; D A Cowan
Journal:  Br J Sports Med       Date:  1991-06       Impact factor: 13.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.